After major pancreatic or gastric surgery (Whipple, distal pancreatectomy, total gastrectomy),
the most common and distressing issues are almost always the same:
feeling full after a few bites, bloating, rapid weight loss, and persistent weakness.
This is not a lack of effort — the digestive system simply cannot absorb enough calories and nutrients in the usual way.
Turning “exhausted all day yet unable to sleep” into steady energy and restful nights
Cancer-related fatigue (CRF) is one of the deepest and most unspoken burdens for the majority of patients.
It is not ordinary tiredness — it is the result of disrupted mitochondrial function, elevated oxidative stress, and persistent low-grade inflammation caused by cancer and its treatments.
Numerous international studies have shown that high-dose intravenous vitamin C (IVC) is one of the safest and most widely recognised supportive options for managing CRF.
Helping you stay energised and emotionally balanced while finding the right dose
After thyroid cancer surgery, Hashimoto’s thyroiditis, or radioiodine treatment, the most challenging phase is often the “dose-finding” transition period:
feeling hot then cold, palpitations, shaky hands, wanting to sleep all day yet never feeling rested, brain fog, and emotional ups and downs.
These symptoms are almost always temporary, and the right supportive strategies can significantly reduce discomfort.
The answer lies in the unique biological profile of each patient’s tumour — RGCC Onconomics Plus® can read it with precision
The same non-small-cell lung cancer: why do some patients remain stable on osimertinib for over a year while others develop resistance within months?
Triple-negative breast cancer: why do some complete standard chemotherapy with tolerable side effects while others require dose reductions due to severe myelosuppression?
Metastatic colorectal cancer: why do certain individuals achieve long-term disease control when specific natural compounds are added, while others see no benefit?
And the gentlest way to open them again
Lymphoma-related fatigue is never just “lack of calories”.
It is actually three invisible pathways blocked at the same time:
● Oxygen can’t reach the cells
● Mitochondria run out of power
● Microcirculation turns into mud
When these three drains are cleared, energy returns like turning on a tap — naturally and steadily.
and the Vital Role of Albumin Infusion in Supportive Care
In pancreatic cancer, chronic pancreatitis, or after pancreatic surgery, loss of exocrine function almost always leads to the dreaded duo of steatorrhea + severe protein-calorie malnutrition. The classic picture is unmistakable:
• Greasy, floating, foul-smelling stools
• Rapid weight loss (5–10 kg or more in a single month)
• Pitting edema in the legs, face, and sometimes the whole body
When the liver is under strain (liver cancer, cirrhosis, chronic hepatitis B/C, fatty liver, or heavy chemotherapy), it becomes “sensitive and tired.” The golden rule for supplementation is simple: Choose only what is easiest for the liver to handle and truly needed right now.
In colorectal cancer, prolonged diarrhea, surgery, poor appetite, and tumor consumption almost always lead to hypoalbuminemia (serum albumin < 3.5 g/dL, often dropping to 2.5–2.8 g/dL in severe cases). Albumin is far more than just a “nutrition marker”—it is the body’s core transport protein. When it stays low for weeks or months, a vicious cycle begins: edema, delayed wound healing, immune collapse, ascites, and even forced treatment breaks.
Nourishing the body while fighting cancer
From diagnosis through treatment and recovery, nearly every colorectal cancer patient experiences some degree of nutrient depletion. Surgery shortens the intestine, chemotherapy suppresses appetite, targeted/immunotherapies trigger diarrhea, and radiation irritates the mucosa. These factors quietly drain protein, vitamins, and minerals. If not replenished thoughtfully and precisely, patients face worsening fatigue, weakened immunity, poor wound healing, and even treatment interruptions.
Every cancer patient is unique. Two people with the same type and stage of lung cancer may have completely different driver mutations (EGFR vs. KRAS vs. no actionable alteration). One breast cancer patient may respond dramatically to conventional chemotherapy, while another achieves better results with specific natural compounds. Choosing the wrong direction not only reduces efficacy but also adds unnecessary toxicity and fatigue. This is why leading cancer centers worldwide have moved away from one-size-fits-all protocols toward genuinely individualized care.